跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE
Approved
STANDARD
ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 16, 2024
Approval ID
e2a69b692cbb9d5c
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
e2a69b692cbb9d5c
Drug Cima Aemps Name
ROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRE
Register Number
1201460003
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2024-08-16
Dosage Form
GRANULADO RECUBIERTO
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
ENTRECTINIB
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 16, 2024
Approval ID
e2a69b692cbb9d5c
Type
Standard
Back to CIMA-AEMPS Approvals